8-K - Crinetics Pharmaceuticals, Inc. | StockGist

Current Report Details

Event Type

Financial Results+3 More

Disclosure

Mandatory

Variant

8-K

Items Reported

2.02

Results of Operations and Financial Condition. On January 5, 2026, Crinetics Pharmaceuticals, Inc. (the “Company” or “Crinetics”) announced certain preliminary

Financial Results

$5.0M

7.01

Regulation FD Disclosure. On January 5, 2026, Crinetics issued a press release and made available a corporate presentation (the “Presentation”) announcing certa

Regulation Fd

8.01

Other Events. On January 5, 2026, Crinetics announced several key updates. The following represents a summary of notable business updates and events: Paltusotin

Other Event

$5.0M

9.01

Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release dated January 5, 2026 99.2 Corporate Presentation 104 Cover Page Inte

Exhibits Only

Source Document

Exhibits (3)

8-K

99.1

EX-99.1

99.2

EX-99.2